Alterations of the p16INK4a gene in resected nonsmall cell lung tumors and exfoliated cells within sputum

International Journal of Cancer

Volumn 98, Issue 5, 2002, Pages 724-731

  Chen, Jung Ta ^a,b   Chen, Yi Chun ^b   Wang, Yu Chien ^c   Tseng, Ruo Chia ^c   Chen, Chih Yi ^a   Wang, Yi Ching ^a,b,c  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

Author keywords

Immunohistochemistry; Loss of heterozygosity; NSCLC; p16INK4agene; Prognosis; Promoter hypermethylation; Sputum

Indexed keywords

DNA; PROTEIN P16;

ADULT; AGED; ARTICLE; CANCER SURGERY; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SPUTUM; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SPUTUM;

EID: 0037051666     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10262     Document Type: Article

References (44)

1. General health statistics, 1999
2. Cancer cell cycles
3. Role of the p16 tumor suppressor gene in cancer
4. INK4A in archival human solid tumors: Correlation with retinoblastoma protein expression
5. 1 control genes status is frequently altered in resectable non-small cell lung cancer
6. INK4A inactivation in non small-cell lung cancers
7. INK4A and cyclin D1 in non-small cell lung carcinoma and their clinical significance
8. Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage
9. INK4B/MTS2, and p18 genes in primary and metastatic lung cancer
10. Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: Relationship with p53 and MDM2 protein expression
11. INK4a (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC)
12. Independent prognostic role of p16 expression in lung cancer
13. Alterations of P16 (MTS1) in node-positive non-small cell lung carcinomas
14. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer
15. Detailed deletion mapping at chromosome 9p21 in non-small cell lung cancer by microsatellite analysis and fluorescence in situ hybridization
16. Molecular damage in the bronchial epithelium of current and former smokers
17. Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas
18. Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers
19. Expression of p16INK4a/pl6α and p19ARF/p16β is frequently altered in non-small cell lung cancer and correlates with p53 overexpression
20. Correlation between methylation status of the p16/CDKN2 gene and the expression of p16 and Rb proteins in primary non-small cell lung cancers
21. INK4a is an early event in lung cancer and a potential biomarker for early diagnosis
22. In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis
23. Inactivation of the CDKN2/pl6/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers
24. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing
25. INK4a expression in resected non-small cell lung tumors
26. p16 protein expression is associated with a poor prognosis in squamous cell carcinomas of the lung
27. p16 inactivation in small-sized lung adenocarcinoma: Its association with poor prognosis
28. Predictive value of expression of p16INK4A, retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancers
29. Loss of p16 and/or pRb protein expression in lung cancer: An immunohistochemical and prognostic study
30. INK4a and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer
31. Nonparametric estimation from incomplete observation
32. The lifetest procedure
33. Widely dispersed p53 mutation in respiratory epithelium: A novel mechanism for field carcinogenesis
34. INK4-cyclin D1) in preinvasive bronchial lesions
35. Biallelic inactivation of hMLHI by epigenetic gene silencing, a novel mechanism causing human MSI cancers
36. Lessons from hereditary colorectal cancer
37. hMLHI promoter hypermethylation is an early event in human endometrial tumorigenesis
38. INK4a promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers
39. Predicting lung cancer by detecting aberrant promoter methylation in sputum
40. Neoplasms of the lung
41. Early lung cancer detection: Results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study
42. Outcome of 51 patients with roentgenographically occult lung cancer detected by sputum cytologic testing: A community hospital program
43. INK4a methylation and p53 mutational status